World First Early Stage Diagnostic Test For Ovarian Cancer, Developed by HealthLinx Scientists
10/29/2008 7:50:07 AM
Medical News Today -- There is new hope for women around the world, with the launch of an early detection test for ovarian cancer. The test, developed in Melbourne by HealthLinx scientists in collaboration with ARL Pathology, is called the OvPlex™ Panel and works by identifying whether five biomarkers (proteins) are present in a blood sample.
comments powered by